Steve serves as Think20’s Chief Marketing Officer. He excelled in various sales management roles for roughly 15 years working for Janssen Pharma, GlaxoSmithKline, Endo Pharma, and Neurocrine Biosciences. Over the past eight years, he has owned and managed GeneMatrix, a global laboratory consulting company. With the combination of Steve’s relevant background and experience, Think20 is uniquely positioned for immediate sales growth and success across all areas of the Cannabis and Hemp testing landscape. He will be leveraging his professional relationships to position Think20 as the preferred diagnostic testing partner for what is ultimately a global opportunity. His passion for the market, and creativity and approach to selling every day, is an expectation he has for himself and the entire Think20 team. Steve earned a Bachelor of Business Administration from Villanova University and is an actively engaged alumnus.
Invited by: Michael Zindell
if the data has not been changed, no new rows will appear.
Day | Followers | Gain | % Gain |
---|---|---|---|
February 25, 2024 | 338 | +4 | +1.2% |
March 20, 2023 | 334 | 0 | 0.0% |
October 01, 2022 | 334 | -2 | -0.6% |
August 10, 2022 | 336 | +2 | +0.6% |
July 04, 2022 | 334 | +2 | +0.7% |
May 28, 2022 | 332 | -1 | -0.4% |
April 20, 2022 | 333 | +2 | +0.7% |
March 13, 2022 | 331 | +3 | +1.0% |
January 14, 2022 | 328 | +4 | +1.3% |
December 08, 2021 | 324 | +2 | +0.7% |